GlassScriptPhysician profile
Adam Reis
NPI 1386058923
$1,774.73
in general payments reported to CMS, 2019-2025
35 companies · $217 in 2025
The $217 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.87 · 2020: $83.76 · 2021: $311 · 2022: $490 · 2023: $270 · 2024: $336 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $188.67 | 2021-2024 | Wegovy, Saxenda |
| Takeda Pharmaceuticals U.S.A., INC. | $163.72 | 2019-2022 | |
| Corium, LLC | $159.81 | 2022-2024 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.33 | 2023-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $118.34 | 2020-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Cranial Technologies, INC | $88.66 | 2020-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $78.72 | 2020-2024 | |
| Sanofi-Aventis U.S. LLC | $69.14 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.18 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $54.63 | 2023-2024 | Gvoke Hypopen |
| Daiichi Sankyo INC. | $54.08 | 2021-2022 | |
| Almatica Pharma LLC | $50.91 | 2022 | |
| Abbott Laboratories | $49.11 | 2021-2022 | |
| Dexcom, INC. | $48.88 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $40.44 | 2022-2024 | Trulicity, Mounjaro, Jardiance |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $37.95 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $37.01 | 2021 | |
| Pfizer INC. | $35.68 | 2022 | |
| Collegium Pharmaceutical, INC. | $33.61 | 2025 | Jornay Pm |
| Amgen INC. | $32.63 | 2022 | |
| Exact Sciences Corporation | $22.02 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $19.65 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $19.43 | 2022 | |
| Inspire Medical Systems, INC. | $18.16 | 2024 | Inspire |
| Mayne Pharma Commercial LLC | $15.54 | 2023 | |
| Verrica Pharmaceuticals INC. | $14.59 | 2025 | Ycanth |
| Abbvie INC. | $13.87 | 2021 | |
| Mylan Pharmaceuticals INC. | $13.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.71 | 2023 | Airduo Digihaler |
| Seqirus USA INC | $12.86 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Neos Therapeutics, LP | $12.71 | 2021 | |
| Endo Pharmaceuticals INC. | $12.59 | 2021 | |
| Phadia US INC. | $12.24 | 2020 | |
| Supernus Pharmaceuticals, INC. | $11.22 | 2021 | |
| Dynavax Technologies Corporation | $8.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Reis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.